The Department of Cytopathology Tata Memorial Hospital was established in 1951, by late Dr. D. J.

Jussawala, former Director of Tata Memorial Centre and Founder Honorary Secretary of Indian Cancer

Society. The laboratory was started as a collaborative effort of the Indian Cancer Society and the Medical Division of the Department of Atomic Energy. The Department of Cytopathology became part of Tata Memorial Centre in May 1972 and merged with the Department of Pathology in February 1978.

The Department of Cytopathology has been accredited by the Indian Academy of Cytologists for diagnostic services since 1980 and later as a training and examination centre since 1984.

Professional competency of Cytopathologists and Cytotechnologists is vital for offering accurate diagnosis. Competency can be assessed by regular and periodic proficiency tests. Participation in External Quality Assurance Scheme (EQAS) is one of the pre-requisites for accreditation and quality control. 

The Department of Cytopathology, initiated EQAS Cytopathology service in 2007 with only a few participants, has grown extensively and at present, more than 400 laboratories (480 participants) from all over India are registered for this programme. The programme covers the diagnostic aspects in cytopathology and consists two cycles per year.

Only registered participant is allowed to evaluate the slides. In the absence of registered participant no other person will be allowed to evaluate the slides.

At the time of slide evaluation, separate evaluation forms should be sent by each signatory if more than one signatory is registered. The feedback for each evaluation form will be provided separately.

EQAS Diagnostic Cytopathology is an annual program which starts by 1st January and ends by 31st December every year. The program consists of circulating a set of actual cytology slides (gynaec, nongynaec and FNAC) among the participants. The pertinent clinical data and format of evaluation is sent to the registered email ID of the participant. After the evaluation, the slide box is to be couriered from one participant to another as per the schedule intimated to the participants.                                                                                                                                                                                              

At the time of evaluation, participants should NOT label the slides or should NOT put any mark on the slide.

Since the same slide box is circulated to all the participants, it is absolutely necessary that the slides should be evaluated within 2 working days of receipt of the same, so as to maintain the continuity of the cycle among all participants within 1 year. The slide box has to be transported carefully without any breakage. In case any participant receives glass slide in broken condition, kindly inform the program  co-ordinator immediately at (cytology@tmc.gov.in) and also the previous participant, so that the reason for the breakage can be found out.

The list of participants will be formed as per the geographical distribution of the labs to facilitate fast transport. The reception of slide box and generating feedback reports will be completed within the same year. The time of receiving the slide box may depend on the number of participants in the year. Each participant will be intimated the list of participants and tentative schedule of their turn.

Kindly note that the duly filled evaluation forms should be submitted to us by email

(cytology@tmc.gov.in) within a period of 2 days of receiving the slide box. 

During the cycle, (Jan-Dec 2024) if there is any change in the Email id, Mobile No., Name and address of the participating lab and the signatory, please inform us well in advance to ensure the smooth transport of the slide box from one participant to another.

EQAS Cytopathology also provides opportunity for re-screening the slides as a corrective measures for participants having average or below average scores. However, the requirement needs to be preconfirmed as per the convenience of participant and TMH.

Kindly mark your envelopes / email with "EQAS Diagnostic Cytopathology" while sending any EQAS correspondence to TMH.

The feedback will be sent to the participant after the evaluation forms are received by us.

TMH-Interventional oncology Conference

EUROSON

The American Association for the Study of Liver Diseases Annual Liver Meeting will be in San Diego, California, in 2024.

Assessments of bone loss and nutritional deficiencies, and lots more.

The AASLD PSC Guidance Support Statement, which includes their stance on access to and insurance coverage of oral vancomycin as a PSC treatment. In part, it reads, “In the absence of a definitive clinical trial, the decision to use an off-label medication should remain between the doctor and the patient … (The lack of such a trial) should not be used as justification to restrict coverage of this treatment if a physician feels it is the right course of action.”

The PSC Partners Statement about the new guidance, which reads, in part, “PSC Partners does not take a position on the use of any specific off-label medication and instead encourages patients to work with their doctor to discuss a treatment plan.” (See the PSC Partners Statement about the Use of Medications Not Approved by the FDA for PSC here.)

Importantly, two future directions proposed in the guidance align with PSC Partners efforts through the WIND Initiative and PROM project. These major research initiatives were launched with support from the PSC community, including some of the authors of this guidance.

American Association for the Study of Liver Diseases

Would you like to register for the “  Endometriosis” session with the AFTHY team?

For non-radiologist MG sonographers by training: DPC n°89152325007

If you are not in any of these cases, registration will be done by the FAFPM. Please contact capeden.endoc@gmail.com directly 

Go to the website https://www.agencedpc.fr/ to finalize your registration

Société Francophone d’Échographie

RSNA 2024: Building Intelligent Connections

RSNA 2024 will center on the bright horizon of radiology and the important role AI plays in empowering radiologists into the future.

Boost your knowledge with high-impact educational courses to stay informed, sharpen your skills and earn CME.

Delve into trending topics shaping radiology and craft your vision for your career and the future of the field.

Cultivate conversations about the future of medical imaging to strengthen and create lasting professional relationships.

RSNA-Radiological Society of North America

To promote general awareness amongst the general population and healthcare professionals about the universality of Gastrointestinal and hepatic disorders, and provide excellent quality care to all by enhancing the standards of education and training of Gastroenterology in India.

Since little is known about the prevalence of Gastrointestinal and Hepatology disorders, out of every 10 adults in the world 4 suffer from gastrointestinal disorders of varying severity. With the advancement of technology and treatment, a large section of the population is not adequately educated including patients in desperate need.

As the national representative for Gastroenterology and Hepatology in India, ISG's role is:

Amplifying awareness of Gastrointestinal and Hepatic disorders

Provide an opportunity for professionals in the field of gastroenterology, hepatology, and related disciplines to come together to learn about the latest research and advancements, collaborate with colleagues, and actively participate in this rapidly advancing field

Facilitating training and research in collaboration with eminent international societies for encouraging young gastroenterologists

Abiding encouragement and support to the global healthcare fraternity in the best possible manner.

ISGCON - Indian Society of Gastroenterology

By using our site, you accept the use of cookies, in order to produce statistical visit analysis. 

We Value Your Privacy

Interested in learning more about SuperSonic Imagine®'s innovative ultrasound technology? Fill out the form below to receive detailed information about our products, services, and how we can help meet your medical team.

Enter your details

logo_supersonic_imagine_1_1_4650fbe9d2_5e66dcab48.webp

Why SuperSonic Imagine®

Mission & Core Values

Brand Journey

Board & Functional Leadership

Our Offices

About SuperSonic Imagine®

SuperSonic® MACH® 20

Fully customizable to fit your needs without compromise.

SuperSonic® MACH® 30

Premium ultrasound system with an abundance of advanced imaging features

SuperSonic® MACH® 40

Our Solutions

Features

Our Products

Instruction For Use

Brochures

Trade Shows & Events

CSR & Sustainability

Publications & White Papers

Customer Testimonial

Community

Join Our Team

Our Global Presence

Offices

Services

Contact Us

social links

At SuperSonic Imagine®, we participate in top industry events to showcase our groundbreaking ultrasound technologies. These events allow us to connect with healthcare professionals, share innovations, and demonstrate how our solutions transform patient care.

Trade Shows & Events

Upcoming Events